Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon

Acta Cirurgica Brasileira

Volumn 28, Issue 5, 2013, Pages 367-372

  Liboredo, Juliana Costa ^a   Anastácio, Lucilene Rezende ^a   Pelúzio, Maria do Carmo Gouveia ^b   Valente, Flávia Xavier ^b   Penido, Luisa Costa Penna ^b   Nicoli, Jacques Robert ^a   Davisson, Maria Isabel Toulson Correia ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

1,2 Dimethylhydrazine; Colon; Mice; Precancerous conditions; Probiotics

Indexed keywords

1, 2 DIMETHYLHYDRAZINE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM ANIMALIS; COLON INJURY; CONTROLLED STUDY; LACTOBACILLUS DELBRUECKII; LIVER; MALE; MESENTERY LYMPH NODE; MORTALITY; MOUSE; NONHUMAN; SPLEEN;

ABERRANT CRYPT FOCI; ANIMALS; BIFIDOBACTERIUM; CARCINOGENS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DIMETHYLHYDRAZINES; LACTOBACILLUS DELBRUECKII; MALE; MICE; PRECANCEROUS CONDITIONS; PROBIOTICS; REPRODUCIBILITY OF RESULTS; SACCHAROMYCES; TIME FACTORS;

EID: 84878343368     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502013000500008     Document Type: Article

References (19)

1. World Health Organization. Cancer. Available from: . Access in November 18, 2008.
2. Reddy BS, Narisawa T, Wright P, Vukusich D, Weisburger JH, Wynder EL. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res. 1975;35(2):287-90.
3. FAO/WHO Expert Consultation: "Guidelines for the Evaluation of Probiotics in Food" London, Ontario (Canada), 2002.
4. Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis. 1998;19:281-5.
5. Gallaher DD, Kill J. The effect of synbiotics on colon carcinogenesis in rats. J Nutr. 1999;129(Suppl. 7):1483-7.
6. Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 2010;31(2):246-51.
7. Bolognani F, Rumney CJ, Pool-Zobel BL, Rowland IR. Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur J Nutr. 2011;40(6):293-300.
8. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane induced colon carcinogenesis in rats. Carcinogenesis. 2002;23(11):1953-60.
9. Liboredo JC, Anastácio LR, Mattos LV, Nicoli JR, Correia MITD. Impact of probiotic supplementation on mortality of induced 1,2-dimethylhydrazine carcinogenesis in a mouse model. Nutrition. 2010;26:779-83.
10. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37(2):147-51.
11. Kulkarni N, Reddy BS. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial b-glucuronidase. Proc Soc Exp Biol Med. 1994;207(3):278-83.
12. Mcintosh GH, Royle PJ, Playne MJ. A probiotic strain of Lactobacillus acidophilus reduces DMH-induced large intestinal tumors in male Sprague Dawley rats. Nutr Cancer. 1999;35(2):153-9.
13. Foo N-P, Yang HO, Chiu H-H, Chan H-Y, Liao C-C, Yu C-K, Wang Y-J. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem. 2011;59:13337-45.
14. Pretlow TP, Barrow BJ, Ashton WS, O'riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 1991;51(5):1564-7.
15. Rodrigues MAM, Silva LAG, Salvadori DMF, Camargo JLV, Montenegro MR. Aberrant crypt foci and colon cancer: comparison between a short-and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 2002;35(3):351-5.
16. Chen X, Fruehauf J, Goldsmith JD, Xu H, Katchar KK, Koon H-W, Zhao D, Kokkotou EG, Pothoulakis C, Kelly CP. Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice. Gastroenterology. 2009;137(3):914-23.
17. Surawicz CM. Probiotics, antibiotic-associated diarrhea and Clostridium difficile diarrhea in humans. Best Pract Res Clin Gastroenterol. 2003;17(5):775-83.
18. Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003;15(6):697-8.
19. Azcárate-Peril MA, Sikes M, Bruno-Bárcena JM. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol. 2011;301:G401-G24.